Allstate Corporation’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.66M Buy
153,970
+41,824
+37% +$3.35M 0.1% 113
2025
Q4
$10.7M Buy
112,146
+57,769
+106% +$5.66M 0.15% 96
2025
Q3
$5.31M Buy
54,377
+50,829
+1,433% +$5.26M 0.12% 93
2025
Q2
$381K Sell
3,548
-47,785
-93% -$4.83M 0.03% 105
2025
Q1
$5.18M Buy
51,333
+7,589
+17% +$764K 0.15% 81
2024
Q4
$3.91M Buy
+43,744
New +$3.85M 0.12% 102
2024
Q3
Sell
-5,779
Closed -$445K 125
2024
Q2
$445K Hold
5,779
0.04% 128
2024
Q1
$396K Sell
5,779
-159
-3% -$10.2K 0.03% 137
2023
Q4
$343K Buy
5,938
+165
+3% +$8.81K 0.02% 148
2023
Q3
$305K Hold
5,773
0.02% 152
2023
Q2
$312K Hold
5,773
0.02% 158
2023
Q1
$289K Sell
5,773
-58,678
-91% -$2.77M 0.02% 154
2022
Q4
$2.98M Buy
64,451
+700
+1% +$30.3K 0.09% 150
2022
Q3
$2.47M Buy
63,751
+7,122
+13% +$286K 0.07% 162
2022
Q2
$2.11M Buy
56,629
+13,615
+32% +$554K 0.07% 180
2022
Q1
$1.91M Sell
43,014
-1,727
-4% -$74.8K 0.05% 259
2021
Q4
$1.9M Buy
44,741
+2,847
+7% +$120K 0.04% 406
2021
Q3
$1.82M Sell
41,894
-3,372
-7% -$149K 0.08% 147
2021
Q2
$1.94M Sell
45,266
-2,996
-6% -$126K 0.06% 149
2021
Q1
$1.86M Buy
48,262
+5,612
+13% +$212K 0.06% 169
2020
Q4
$1.53M Buy
42,650
+7,139
+20% +$257K 0.05% 188
2020
Q3
$1.36M Sell
35,511
-6,076
-15% -$234K 0.04% 175
2020
Q2
$1.46M Sell
41,587
-11,321
-21% -$408K 0.05% 181
2020
Q1
$1.73M Sell
52,908
-82,507
-61% -$3.22M 0.07% 134
2019
Q4
$6.12M Buy
135,415
+499
+0.4% +$20.9K 0.11% 105
2019
Q3
$5.49M Hold
134,916
0.09% 120
2019
Q2
$5.8M Buy
134,916
+17,069
+14% +$657K 0.1% 103
2019
Q1
$4.52M Hold
117,847
0.12% 118
2018
Q4
$4.17M Buy
+117,847
New +$4.27M 0.14% 111
2017
Q3
Sell
-64,201
Closed -$1.78M 62
2017
Q2
$1.78M Sell
64,201
-43,911
-41% -$1.17M 0.09% 98
2017
Q1
$2.69M Buy
+108,112
New +$2.63M 0.16% 89

Other funds holding BSX